It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The glucagon-like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in metabolism. Presently, its visualization is limited to genetic manipulation, antibody detection or the use of probes that stimulate receptor activation. Herein, we present LUXendin645, a far-red fluorescent GLP1R antagonistic peptide label. LUXendin645 produces intense and specific membrane labeling throughout live and fixed tissue. GLP1R signaling can additionally be evoked when the receptor is allosterically modulated in the presence of LUXendin645. Using LUXendin645 and LUXendin651, we describe islet, brain and hESC-derived β-like cell GLP1R expression patterns, reveal higher-order GLP1R organization including membrane nanodomains, and track single receptor subpopulations. We furthermore show that the LUXendin backbone can be optimized for intravital two-photon imaging by installing a red fluorophore. Thus, our super-resolution compatible labeling probes allow visualization of endogenous GLP1R, and provide insight into class B GPCR distribution and dynamics both in vitro and in vivo.
Glucagon-like peptide-1 receptor is an important regulator of appetite and glucose homeostasis. Here the authors describe super-resolution microscopy and in vivo imaging compatible fluorescent probes, which reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics in islets and brain.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

















1 University of Birmingham, Institute of Metabolism and Systems Research (IMSR), and Centre of Membrane Proteins and Receptors (COMPARE), Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486); Birmingham Health Partners, Centre for Endocrinology, Diabetes and Metabolism, Birmingham, UK (GRID:grid.6572.6)
2 University of Birmingham, Centre for Liver Research, College of Medical and Dental Sciences, Institute for Immunology and Immunotherapy, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
3 University of Birmingham, Genome Editing Facility, Technology Hub, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486)
4 Imperial College London, Division of Diabetes, Endocrinology and Metabolism, Section of Investigative Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
5 University of British Columbia, Diabetes Research Group, BC Children’s Hospital Research Institute, Vancouver, BC, Canada; Department of Surgery, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)
6 University College London, Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology & Pharmacology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
7 University of Oxford, Oxford Centre for Diabetes, Endocrinology & Metabolism, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
8 Imperial College London, Division of Diabetes, Endocrinology and Metabolism, Section of Cell Biology and Functional Genomics, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
9 University of Manchester, Faculty of Biology, Medicine and Health, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
10 University of Cambridge, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
11 Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
12 Max Planck Institute for Medical Research, Optical Microscopy Facility, Heidelberg, Germany (GRID:grid.414703.5) (ISNI:0000 0001 2202 0959)
13 Max Planck Institute for Medical Research, Department of Chemical Biology, Heidelberg, Germany (GRID:grid.414703.5) (ISNI:0000 0001 2202 0959)